Becker's Healthcare January 31, 2024
Claire Wallace

Medical device company Centinel Spine saw its Prodisc total disc replacement sales grow 56% in the ASC setting between 2022 and 2023.

Prodisc sales overall were up 55% from the year prior, at $70 million, according to the company’s year-end financial results. Centinel focuses exclusively on treating cervical and lumbar spinal disease with its total disc replacement technology platform. Its growth in the ASC space signals an overall trend of spinal procedures shifting from the inpatient to the outpatient setting.

“The past decade has shown us that orthopedic and spine surgery (in the properly indicated patient) can be performed in a safer, more efficient and cost-saving manner compared to the traditional large hospital setting. This migration of surgeries to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ASC, Provider
ASCs' growing financial storm
The administrative burdens holding back ASC growth
The cost disparity of colonoscopies at ASCs vs. hospitals
Riding the wave of ASC growth — what's next for industry success
St. Tammany Health System to open $75M surgery center

Share This Article